Early i-IFTA: Associated factors and impact on graft outcome.
=0.060). I-IFTA0/1 and 2/3 presented comparable one-year graft outcomes, including donor-specific antibodies (DSA), rejection occurrence, and graft function. In conclusion, early i-IFTA is an ambiguous and non-specific lesion that can be associated with ischemia/reperfusion injury, early BK nephropathy, or rejection.
Authors
- Elodie Miquelestorena‐Standley (ORCID: https://orcid.org/0000-0002-6375-3734)
- Juliette Gueguen (ORCID: https://orcid.org/0000-0001-5695-5373)
- Damien Sizaret
- Tristan de Nattes (ORCID: https://orcid.org/0000-0002-3714-8768)
- C. Bonenfant
- Marion Rabant (ORCID: https://orcid.org/0000-0001-5696-6478)
- Philippe Gatault (ORCID: https://orcid.org/0000-0003-1664-2879)
- Antoine Taillandier (ORCID: https://orcid.org/0009-0000-4832-0888)
- Marie‐Christine Machet
- Lucie Maigret
- Claire Kizlik
Institutions
- Université de Tours (FR)
- Hôpital Necker-Enfants Malades (FR)
- Inserm (FR)
- Université Paris Cité (FR)
- Institut Necker Enfants Malades (FR)
- Centre Hospitalier Universitaire de Tours (FR)
- Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine (FR)
- Université de Rouen Normandie (FR)
Publication Details
- Journal
- PubMed
- Published
- 2026-04-01
- DOI
- https://doi.org/10.14670/hh-25-005
- Primary Topic
- Electrospun Nanofibers in Biomedical Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00